‘Don’t Buy the Dip,’ Says Morgan Stanley About Hims & Hers Stock
Hims & Hers Health (NYSE:HIMS) shares were on a massive run, but that momentum hit a wall recently. Since its peak on ...
Author Sahil Bloom shares tips on building wealth beyond money
Sahil Bloom, New York Times bestselling author of “The 5 Types of Wealth: A Transformative Guide to Design Your Dream Life,” joins TODAY to share advice for building “wealth” in your life beyond money ...
How a nap under the right conditions could boost brain health
Researchers at San Jose State University are looking at the benefits of taking a power nap and finding that it can improve brain function, including boosting alertness, mood, memory and more — but how ...
Giftify, Inc. Reports Surge in Pharmacy Retailer Gift Card Demand Following GLP-1 Medication Savings Initiative
Record Inventory Increase Meets Growing Consumer Demand for Healthcare Cost-Saving SolutionsSurge Driven by Ozempic and Zepbound Prescription ...
US FDA to Hold off Action on Weight-Loss Drug Copies Pending Court Ruling
In its Monday update, the FDA clarified that state-licensed compounding pharmacies and outsourcing facilities — which make ...
BioPharma Dive4d
Novo’s Wegovy successor disappoints in second large trial
A study in people with obesity and diabetes again found CagriSema helps people lose weight, but not by enough to clearly ...
Novo Nordisk shares fall on weight-loss drug trial
Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.